08:24 AM EST, 01/02/2025 (MT Newswires) -- Clearmind Medicine ( CMND ) said Thursday that the Macau International Intellectual Property Office has granted a patent for its binge behavior treatment.

The patent is directed to be used a a primary amine aminoindan compound for binge behavior regulation, including such compounds beyond its psychedelic molecule, 5-methoxy-2-aminoindan.

Shares of Clearmind Medicine ( CMND ) were up over 7% in premarket activity Thursday.

Price: 1.48, Change: +0.10, Percent Change: +7.25